Rota
Flash              link to PATH.org
    A news update from the Rotavirus Vaccine Program*


  


 


    Recent articles published in the New England Journal of Medicine presenting landmark data on the safety and efficacy of rotavirus vaccines in Latin America, Europe, and the United States are now available on-line in Spanish, French, and Russian.

     

    As part of our global effort to facilitate access to the evidence base for rotavirus vaccines, we hope that making these important technical resources and information available in multiple languages will contribute to an improved understanding of the potential impact of these life-saving vaccines.  We appreciate the cooperation of the New England Journal of Medicine in making these studies available to a global audience.

     

    The studies are available in English, Spanish, French, and Russian translation from PATH's Vaccine Resource Library. Click on the document links below to download a PDF version. Additional rotavirus disease and vaccine resources may be accessed at www.path.org/vaccineresources/rotavirus.  


    Best regards,

     

     

    John R. Wecker, PhD
    Director, Rotavirus Vaccine Program

    Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis (2006)
    Ruiz-Palacios G, et al. New England Journal of Medicine. 354(1):11-22.


    English (233 KB PDF)     Español (233 KB PDF)    
    Français (244 KB PDF)     Russian (253 KB PDF)


    Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine (2006)

    Vesikari T, et al. New England Journal of Medicine. 354(1):23-33.


    English (1.17 MB PDF)    Español (216 KB PDF)    
    Français (221 KB PDF)    Russian (254 KB PDF)

     

    The promise of new rotavirus vaccines
    Glass R, Parashar U. New England Journal of Medicine. 354(1): 75-77.


    English (694 KB PDF)     Español (230 KB PDF)     Français (232 KB PDF)    Português (247 KB PDF)
    Russian (245 KB PDF)



     

     * The Rotavirus Vaccine Program is a collaboration of PATH, CDC, and WHO, supported by the GAVI Alliance.